Related by context. All words. (Click for frequent words.) 70 IMA# 69 TBC# 69 lomitapide 69 Archexin 68 JAK inhibitor 68 Onconase 68 Mipomersen 67 forodesine 67 drug GAP #B# 67 nalbuphine ER 67 ApoB SNALP 67 liprotamase 67 Panzem 67 indibulin 67 ATL# [001] 67 Phase IIb clinical trials 67 OvaRex R 67 MAXY VII 67 ospemifene 67 Troxatyl 67 AEG# 67 Exherin TM 67 ThGRF 67 OHR/AVR# 67 DXL# 67 therapeutic monoclonal antibody 67 Fibrillex 67 CBLC# 66 vidofludimus 66 torezolid phosphate 66 phase IIb clinical 66 glucokinase activator 66 OvaRex ® MAb 66 CEQ# 66 Fodosine 66 Asentar 66 Phase #b/#a clinical 66 tramiprosate 66 RhuDex ® 66 oral prodrug 66 ONCONASE R 66 Elagolix 66 Syncria 66 lumiliximab 65 HCV protease inhibitors 65 MAGE A3 ASCI 65 Bicifadine 65 FOLOTYN ® 65 Lisofylline LSF 65 midstage trials 65 Tolamba 65 incyclinide 65 pradefovir 65 Xanafide 65 Virulizin ® 65 lixivaptan 65 Spiegelmer ® 65 metaglidasen 65 targeted radiotherapeutic 65 ATL/TV# 65 Zybrestat 65 elacytarabine 65 PSMA ADC 65 cannabinor 65 pharmacokinetic PK study 65 Urocidin 65 apricitabine ATC 65 BNC# 65 Personalized Immunotherapy 65 aleglitazar 65 GAP #B# 65 Vernakalant 65 Pimavanserin 65 tiapamil 65 bardoxolone 65 tolevamer 65 Chemokine Therapeutics 65 RhuDex 65 GSK# [002] 65 KNS # 64 Nicole Onetto MD 64 TRO# 64 mertansine 64 Virulizin R 64 Aviptadil 64 Dacogen decitabine 64 phase IIb trial 64 IND submission 64 RNAi therapeutic targeting PCSK9 64 dirucotide 64 CCR9 antagonist 64 CDP# 64 faropenem 64 Factor VIIa 64 alvespimycin 64 Canvaxin 64 HQK 64 Proxinium TM 64 Virulizin 64 DPX Survivac 64 Phase #b/#a 64 Solazed 64 inecalcitol 64 GLP toxicology studies 64 Apo AI 64 Fibrillex TM 64 OvaRex 64 Lixivaptan 64 faropenem medoxomil 64 PEGylated interferon 64 TACI Ig 64 MGN# 64 Albugon 64 antisense drug 64 DCCR 64 oxypurinol 64 acyclovir Lauriad R 64 telomerase therapeutic 64 MAXY G# 64 Phase IIb trials 64 Vidaza azacitidine 64 phase IIa clinical 64 IRX 2 64 Arcalyst 64 budesonide foam 64 Phase Ib clinical trials 64 FM VP4 64 personalized immunotherapy 64 Egrifta 64 Alzhemed TM 64 Allovectin 7 64 Cloretazine ® 64 Relivar 64 midstage clinical 64 Corlux 64 tramiprosate Alzhemed TM 64 CTAP# Capsules 64 immunotherapeutic vaccine 64 THR beta agonist 64 Zemiva TM 64 novel therapeutic antibodies 64 GLP1 agonist 63 prostone 63 ELACYT 63 Phase 2a clinical trials 63 TOCOSOL 63 PEG SN# 63 TOCOSOL Camptothecin 63 ocrelizumab 63 SMT C# 63 EndoTAG TM -1 63 OMP #M# 63 riociguat 63 BZL# 63 ACV1 63 MBP# [001] 63 Zemplar Capsules 63 NV1FGF 63 Lupuzor 63 Azedra TM 63 Cinquil 63 PF # [002] 63 atacicept 63 Balaglitazone 63 refractory gout 63 elotuzumab 63 ulimorelin 63 GVAX ® 63 Ostabolin C 63 Panzem R 63 anti CD3 monoclonal 63 tremelimumab 63 Myocet 63 Maxy G# 63 preclinically 63 DOS# 63 DCVax R 63 cancer immunotherapies 63 SNT MC# 63 Onalta 63 Cloretazine 63 TELINTRA 63 huC# DM4 63 renin inhibitor 63 Panzem R NCD 63 Memryte 63 Surfaxin LS 63 Phase IIIb clinical 63 YONDELIS 63 JAK3 inhibitor 63 rhFVIIa 63 Tocosol Paclitaxel 63 Protexia ® 63 Prodarsan ® 63 SinuNase ™ 63 Annamycin 63 Prosaptide 63 Civacir 63 Cleviprex TM clevidipine 63 phase IIb study 63 oral salmon calcitonin 63 TRV# [001] 63 next generation URAT1 63 R#/MEM # 63 renin inhibitors 63 ATL# [002] 63 PhG alpha 1 63 LymphoStat B TM 63 KIACTA ™ 63 Cogane 63 dexpramipexole 63 octreotide implant 63 Kamada AAT 63 PHX# 63 BioNumerik 63 GRNVAC1 63 CytoFabTM 63 alkylating agent 63 Phase 2b clinical trials 63 ProSavin 63 ALN PCS 63 Capesaris 63 NEUGENE R 63 Aplidin 63 Begins Dosing 63 Theratope 63 NeuroSTAT ® 63 candidate TNFerade biologic 63 rEV# 63 CCR5 mAb 63 Cardio Vascu Grow 63 Bezielle 63 Davanat 63 RhuDex R 63 Intravenous CP 63 SUTENT ® 63 TKM ApoB 63 trastuzumab DM1 63 eprotirome 62 Plenaxis TM 62 Ceflatonin 62 Onco TCS 62 Safinamide 62 Fx #A 62 glucagon receptor 62 Zalypsis 62 rxRNA 62 tramiprosate ALZHEMED TM 62 Squalamine 62 PNP inhibitor 62 Angiocept 62 Ozarelix 62 selective modulator 62 NVA# 62 diarrhea predominant irritable 62 midstage studies 62 AFREZZA ® 62 Diamyd ® 62 Acapodene 62 rhThrombin 62 Omacetaxine 62 AQ4N 62 motesanib 62 product ColonSentry TM 62 AERx iDMS 62 VitiGam 62 PANVAC VF 62 EVIZON TM 62 TPI ASM8 62 CA9 SCAN 62 Aflibercept 62 ZADAXIN ® 62 Cand5 62 Phase IIa trial 62 deforolimus 62 Darusentan 62 Muraglitazar 62 Curaxin 62 Xcytrin R 62 Rhucin ® recombinant 62 XP #L 62 Cetrorelix 62 MKC# MT 62 intranasal formulation 62 reslizumab 62 isavuconazole 62 anticancer compound 62 compound ISA# 62 Hematide ™ peginesatide 62 GeneICE 62 oral methylnaltrexone 62 inhibit metastasis 62 romazarit 62 Veronate 62 EP #R 62 HuMax TAC 62 Convivia TM 62 HGS ETR1 62 Zoraxel 62 PDE4 inhibitor 62 Posiphen TM 62 INCB# [001] 62 Spiegelmer 62 Iluvien ® 62 #D#C# 62 AAG geldanamycin analog 62 ARIKACE ™ 62 leading oral taxane 62 Viramidine 62 Tumour Vascular Disrupting Agent 62 Proellex TM 62 brivaracetam 62 Silodosin 62 Solulin 62 Allovectin 7 R 62 preclinical efficacy 62 anticoagulant reversing agent 62 SERMs 62 INS# [001] 62 hypoxia activated prodrug 62 adrenergic regulation 62 Elafin 62 Evoltra ® 62 albiglutide 62 MyVax ® 62 liposomal formulation 62 Elocalcitol 62 ReN# 62 Itopride 62 selective androgen receptor modulator 62 Dacogen injection 62 ularitide 62 tosedostat 62 Omthera 62 E2F Decoy 62 Pancreate 62 generation URAT1 inhibitor 62 multicenter Phase II 62 tafamidis 62 Tesmilifene 62 immunosuppressant therapies 62 ACOMPLIA R 62 tanespimycin 62 OncoVEX 62 Atiprimod 62 Anavex #-# 62 IV Busulfex 62 Phenoptin 62 rindopepimut 62 Zerenex 62 trastuzumab DM1 T DM1 62 metabolite identification 62 Ramoplanin 62 Phase Ib clinical 62 Dapagliflozin 62 inhaled AAT 62 XmAb# 62 RLY# 62 PRT# 62 Prodarsan R 62 mTOR inhibition 62 INT# [002] 62 OMNARIS HFA 62 Phase #b/#a trial 62 LAF# 62 Tesofensine 62 Proquin XR 62 UPLYSO 62 obatoclax 62 HepeX B 62 Insegia 62 Trofex TM 62 cMET 62 NeuVax 61 Azedra 61 phase IIb III 61 Nanobody 61 DermaVir 61 Cytolin ® 61 Sulonex TM 61 Nanobody ® 61 NP2 Enkephalin 61 trodusquemine 61 EnzymeRx 61 Sym# 61 phase IIb 61 sitaxsentan 61 compound AEOL # 61 dexanabinol 61 Trofex 61 Viprinex TM 61 SinuNase 61 LibiGel ® 61 gastro intestinal inflammation 61 triphendiol 61 Nuvion 61 theranostic 61 epothilones 61 PLK1 SNALP 61 CMV vaccine 61 Phase Ib study 61 LEP ETU 61 epothilone 61 BEXXAR 61 bosutinib 61 adipiplon 61 RSD# oral 61 efaproxiral 61 Synavive 61 Genasense ® oblimersen 61 QNEXA ® 61 demonstrated antitumor activity 61 Phase III ADT 61 Zingo TM 61 Phase 1a clinical 61 Erbitux cetuximab 61 Tykerb lapatinib 61 oral picoplatin 61 gepirone ER 61 apricitabine 61 biased ligand 61 Unit Dose Budesonide 61 Aganocide ® 61 sodium glucose transporter 61 LymphoStat B belimumab 61 BrachySil TM 61 systemic RNAi 61 BrachySil ™ 61 Fenretinide 61 PDE# inhibitors 61 candidate Zenvia 61 Milnacipran 61 YONDELIS R 61 HDL Selective Delipidation 61 oral PTH 61 eniluracil 61 Elesclomol 61 PSN# [002] 61 oral taxane 61 JP-#/fipamezole 61 Aclidinium 61 VivaGel TM 61 IL# PE#QQR 61 Chimigen TM 61 Alvesco R 61 RezularTM 61 Degludec 61 masitinib 61 otelixizumab 61 canakinumab 61 mSEPT9 biomarker 61 phase Ib 61 crofelemer 61 MKC# MKC# PP 61 JAK inhibitors 61 AMPK activators 61 lucinactant 61 FluCide 61 Lu AA# 61 Inc. OTCBB IRBS 61 methylnaltrexone 61 CRMD# 61 bicifadine 61 Plicera 61 Tyrima 61 therapeutic monoclonal antibodies 61 successfully commercialize Iluvien 61 Actimmune ® 61 MKC# 61 Daclizumab 61 multiple myeloma MM 61 CR# vcMMAE 61 Septin9 61 Sulonex 61 methylnaltrexone bromide 61 Tarvacin TM 61 opioid induced bowel dysfunction 61 bardoxolone methyl 61 omacetaxine mepesuccinate 61 Soliris eculizumab 61 acetonide FA 61 aldehyde dehydrogenase ALDH2 deficiency 61 GLYX 61 generation purine nucleoside 61 AFREZZA TM 61 Desmoteplase 61 BLA filing 61 siRNA therapeutics 61 Fentanyl TAIFUN R 61 Lovaxin C 61 pharmacological chaperone 61 Solazed TM 61 CVBT #H 61 HuMax CD# 61 midstage clinical trials 61 Familial Adenomatous Polyposis FAP 61 Aurora kinase inhibitor 61 HuLuc# 61 Prednisporin TM 61 LHRH antagonists 61 Aurora kinase inhibitors 61 vascular disrupting agent 61 Phase lll 61 KRN# 61 Fabry Disease 61 alemtuzumab Campath 61 GRN# 61 Reverset 61 Octreotide 61 delivery polymer matrix 61 Tasimelteon 61 Homspera TM 61 VitiGam TM 61 AZX# 61 TLK# 61 including eniluracil ADH 61 SILENOR 61 seliciclib CYC# 61 Hedgehog antagonist 61 phase IIa 61 davalintide 61 BrachySil 61 novel VDA molecule 61 Rezular 61 Telatinib 61 TKM PLK1 61 Potelligent Technology 61 Phase 2a clinical 61 Vascugel 61 immune modulating 61 tesmilifene 61 monoclonal antibody therapeutics 61 EndoTAG TM 61 CORT # 61 Androxal ® 61 Symadex 61 NEBIDO 61 thymalfasin 61 Affinitak 61 compound INCB# 61 Oasmia 61 pivotal bioequivalence 61 ALGRX 61 ATHX 61 vosaroxin 61 ADVANCE PD 61 antibody MAb 61 VA# [002] 61 OncoVEX GM CSF 61 Chrysalin 61 Ocrelizumab 60 Human cl 60 drug figitumumab 60 Benlysta belimumab 60 Clavis Pharma 60 metastatic colorectal 60 Campath ® 60 Medidur FA 60 lipid particle 60 Telintra 60 Velcade bortezomib 60 volociximab 60 mesylate tablets 60 vivo validation 60 trial evaluating PRX# 60 Celator 60 DPP4 inhibitor 60 Lorianne Masuoka MD 60 Relovair 60 afamelanotide 60 H#N# VLP vaccine 60 preclinical toxicology 60 registrational trial 60 Atrasentan 60 Isis antisense 60 SinuNase TM 60 darapladib 60 Mycograb 60 Aurexis 60 vascular disrupting agents 60 Quinamed 60 Fentanyl Taifun 60 RNA interference RNAi therapeutics 60 allosteric modulator 60 novel peptides 60 figitumumab 60 Sebivo 60 Arikace 60 postoperative ileus 60 omega interferon 60 glufosfamide 60 evaluating tivozanib 60 Cannabinor 60 Hematide ™ 60 Phase IIa clinical trials 60 Phase IIa trials 60 SNT-MC#/idebenone 60 A3 adenosine receptor 60 PNT# 60 PORxin TM 60 RIGScan CR 60 Diamyd R 60 Abiraterone acetate 60 NP2 60 Oncogenex 60 oxymorphone ER 60 immunotherapeutic agent 60 CB2 selective receptor agonist 60 Ron Bentsur 60 APEX PD 60 Aganocide 60 Vectibix panitumumab 60 PSN# [001] 60 Luramist 60 rALLy clinical trial 60 Pertuzumab 60 ruxolitinib 60 Phase Ib IIa 60 Nexavar sorafenib 60 ganetespib 60 initiated Phase Ib 60 Georges Gemayel 60 Rasagiline 60 XmAb 60 Nasdaq OPTR 60 CA4P 60 RECOTHROM R 60 BST CarGel R 60 Nuedexta 60 candidate XP# 60 Onalta ™ 60 olaparib 60 fostamatinib disodium 60 Phase III Pivotal 60 MAb therapy 60 oral rivaroxaban 60 QVA# 60 Nasdaq RDEA 60 CytoFab 60 AKT inhibitor 60 Ophena TM 60 AZILECT ® 60 AeroLEF TM 60 NASDAQ INFI 60 Thiarabine 60 HuMax CD4 60 drug ISA# 60 Heplisav 60 corticosteroid dexamethasone 60 Mpex 60 S/GSK# 60 Hsp# inhibitor 60 virus HCV protease inhibitor 60 Sphingomab TM 60 TG# [003] 60 RSR# 60 velafermin 60 receptor tyrosine kinase inhibitor 60 tezampanel NGX# 60 Oglemilast 60 acyclovir Lauriad ® 60 Pradefovir 60 TSX VENTURE SVA 60 mGluR2 NAM 60 Vidofludimus 60 #I TM# 60 Reclast Aclasta 60 Anidulafungin 60 proteasome inhibitor 60 JAK2 inhibitor 60 Phase 1b clinical trials 60 CYT# potent vascular disrupting 60 Alocrest 60 Icatibant 60 investigational monoclonal antibody 60 TNFerade ™ 60 Cloretazine R 60 non nucleoside inhibitor 60 oral talactoferrin 60 ONTAK 60 epigenetic therapies 60 CYT# QbG# 60 GSK '# 60 Interferon alpha 60 EOquin 60 TOCOSOL Paclitaxel 60 Menerba 60 HuCAL antibodies 60 angiogenesis inhibitor 60 Phase IIa clinical 60 ALS #-# 60 oral ghrelin agonist 60 Octreolin 60 Ceflatonin R 60 BCR ABL inhibitors 60 tubulin inhibitor 60 GALNS 60 ASONEP 60 novel immunotherapies 60 STRIDE PD 60 PEG PAL 60 Aerosurf 60 Dendreon Provenge 60 depsipeptide 60 Marqibo TM 60 tranilast 60 Olmesartan 60 PCK# 60 OncoVex 60 MyVax personalized immunotherapy 60 humanised monoclonal antibody 60 Novolimus 60 Darinaparsin 60 ACAPODENE 60 optimal dosing regimens 60 HGS# 60 molecular imaging radiopharmaceutical 60 dermatology biopharmaceutical company 60 relapsed leukemia 60 bevasiranib 60 Locteron ® 60 TREDAPTIVE 60 vaccine GRNVAC1 60 Urokinase 60 Somatuline Depot 60 HyACT 60 Epanova 60 Cethrin 60 Nanobody R 60 pexiganan 60 Mesafem 60 R#/MEM 60 torsemide ER 60 rilonacept 60 oral ridaforolimus 60 cobiprostone 60 hepatitis B vaccine Heplisav 60 L BLP# 60 biobetter 60 inhaled liposomal ciprofloxacin 60 ONCONASE 60 RenaZorb TM 60 isoform selective 60 OMAPRO 60 Tesetaxel 60 rBChE 60 Zosano 60 MEK inhibitor 60 dextofisopam 60 Spiro Rombotis President 60 macitentan 60 Tavocept 60 radiotherapeutic 60 Emezine 60 midstage clinical trial 60 GED aPC 60 oncolytic virus therapies 60 HSP# inhibitor 60 vemurafenib 60 Immunogen 60 aurora kinase 60 BXT # 60 Cimzia TM 60 anticancer therapeutics 60 vaso occlusive crisis 60 cilengitide 60 regorafenib 60 zanolimumab 60 TOPIGEN 60 Kevetrin ™ 60 Evamist TM 60 rasagiline tablets 60 Manja Bouman CEO 60 PEGylated Fab fragment 60 Sirona Biochem 60 polysaccharide polymer 60 SLx 59 tesofensine 59 GLPG# 59 REP# 59 6R BH4 59 kidney urologic 59 Argatroban 59 baminercept 59 compound KOS 59 MVA BN R 59 Soliris TM eculizumab 59 cariprazine 59 levocetirizine 59 Zolinza 59 Addrenex 59 Cutanea 59 NPC 1C 59 Dr. Sosne 59 personalized dendritic cell 59 nanoviricides 59 ORMD 59 teplizumab 59 Dasatinib 59 photoprotective drug 59 Sutent sunitinib 59 synthetic retinoid 59 aerosolized AAT 59 Guanilib 59 Harbor BioSciences 59 arzoxifene 59 MYDICAR 59 Angiotensin Therapeutic Vaccine 59 investigational compound 59 GTC recombinant human 59 MEK inhibitor RDEA# 59 preclinical pharmacokinetic 59 Cholestagel 59 carcinoid syndrome 59 Amrubicin 59 Reolysin 59 Fibrin Pad 59 bovine thrombin 59 PRESEPT study 59 cediranib 59 NuroPro R 59 Enobia 59 OXIGON TM 59 phase Ib clinical 59 SCIB1 59 initiate Phase 2b 59 FoldRx 59 MyVax R 59 LEUKINE 59 Curaxin CBLC# 59 Tezampanel 59 CGEN # 59 BAY #-# 59 Vicriviroc 59 azilsartan medoxomil 59 CIMZIA TM 59 XYOTAX TM 59 defensin mimetic antibiotic 59 Brussels THR 59 Cethrin R 59 non alcoholic steatohepatitis 59 motexafin gadolinium Injection 59 talactoferrin 59 Flutiform TM 59 Aquinox 59 DepoVax ™ 59 EGS# 59 Achieves Primary Endpoint 59 elvucitabine 59 Sanctura XR 59 ATG Fresenius S 59 OTCBB CVBT 59 OLEPTRO 59 DCVax 59 squalamine 59 LHRH antagonist 59 StemEx R 59 IMC #B 59 pharmacokinetic characteristics 59 ColonSentry TM 59 CG# [003] 59 PI3K inhibitors 59 chemopreventive agent 59 Loramyc R 59 PD LID 59 small molecule Hedgehog 59 ISTODAX 59 R sorafenib tablets 59 Technosphere Insulin 59 Gemin X 59 Vicinium TM 59 THALOMID 59 hyaluronidase enzyme 59 Nestorone 59 NDA resubmission 59 adalimumab Humira 59 LAB CGRP 59 senicapoc 59 Aloxi injection 59 PrevOnco ™ 59 Ostarine 59 PGL# 59 pafuramidine maleate 59 ISIS # 59 candidate epratuzumab 59 Pazopanib 59 Etubics 59 investigational hepatitis B 59 vernakalant oral 59 OMNARIS Nasal Spray 59 Aurograb 59 neratinib 59 Zavesca R 59 LentiVector technology 59 guanfacine extended release 59 Pivotal Phase III 59 gefitinib Iressa 59 thetreatment 59 Anthim 59 davunetide intranasal AL 59 Nalmefene 59 cathepsin K inhibitor 59 Ophena 59 Kosan dependence 59 EDEMA3 59 CD# CEA 59 ocular formulation 59 Adentri 59 PREOS R 59 kallikrein 59 BRAF inhibitor 59 Xinlay 59 muscarinic receptor agonist 59 Phase #/#a trial 59 AOD# [002] 59 Sudhir Agrawal D.Phil 59 Sopherion 59 immunotherapeutics 59 anti amnesic 59 GW# [003] 59 R roscovitine 59 sodium thiosulfate STS 59 ANAVEX #-# [001] 59 TRANSDUR Bupivacaine 59 Ruconest 59 PRTX 59 SUCCEED trial 59 Nebido 59 Tß4 59 resolvin 59 ELND# 59 orBec 59 visilizumab 59 Sinobiopharma 59 OVATURE 59 Phase Ib II 59 PS# [001] 59 ketolide antibiotic 59 Abstral ® 59 outlicensed 59 Prestara 59 oral anticancer 59 forodesine hydrochloride 59 Perforomist ™ Inhalation Solution 59 adecatumumab MT# 59 G#DT 59 Phase 2a trial 59 thalidomide Thalomid 59 DDP# 59 BioVant 59 oncolytic virus therapy 59 non nucleoside HCV 59 Toraymyxin TM 59 LEVADEX ™ 59 Cintredekin Besudotox 59 Cytochroma 59 alogliptin 59 potency selectivity 59 DepoVax TM 59 human microdosing 59 Syntonix 59 candidate deforolimus 59 Valtropin 59 Vidaza R 59 EGRIFTA 59 valopicitabine 59 anticancer activity 59 p# inhibitor 59 Triolex 59 Onglyza saxagliptin 59 CINTREDEKIN BESUDOTOX 59 AVN# [001] 59 PDX pralatrexate 59 BRIM3 59 VersaFilm 59 cytokine refractory 59 delta opioid receptor 59 Cethromycin 59 ALN TTR 59 candidate AQ4N 59 betrixaban 59 Panzem ® 59 CIMZIA ™ 59 pseudobulbar affect PBA 59 SUPPRELIN R LA 59 atrasentan 59 elesclomol 59 BEMA Granisetron 59 Azilect ® 59 Chimigen 59 non nucleoside 59 tezampanel 59 lorvotuzumab mertansine 59 TH# [003] 59 sorafenib tablets 59 Aegerion 59 romidepsin novel 59 Qutenza TM 59 Anturol TM